At Omics! Omics!, Keith Robison reports that Pfizer has filed a patent based on a Gene Logic drug repositioning effort. Drug repositioning is finding new uses for advanced drugs that ultimately were never approved, and Gene Logic is just one of a handful of companies hoping to make money off these compounds. The question remains, will it be the big pharmas or small biotechs that can actually get these through clinical trials?

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.